2 weeks Ago By Defense World Staff
Brandes Investment Partners LP raised its holdings in Kenvue Inc. ( NYSE:KVUE – Free Report ) by 3,620.9% in the 2nd quarter, according to its most recent 13F filing with the SEC.
The fund owned 1,615,904 shares of the company’s stock after acquiring an additional 1,572,476 shares during the period. Brandes Investment Partners LP owned 0.08% of Kenvue worth $29,407,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. Marathon Capital Management raised its holdings in Kenvue by 0.3% in the 2nd quarter.
Marathon Capital Management now owns 149,699 shares of the company’s stock valued at $2,722,000 after acquiring an additional 514 shares during the last quarter. Manchester Capital Management LLC grew its stake in shares of Kenvue by 80.8% during the 1st quarter.
Manchester Capital Management LLC now owns 1,186 shares of the company’s stock valued at $25,000 after buying an additional 530 shares during the period. Poehling Capital Management INC. grew its stake in shares of Kenvue by 0.
5% during the 2nd quarter. Poehling Capital Management INC. now owns 104,934 shares of the company’s stock valued at $1,908,000 after buying an additional 547 shares during the period.
MV Capital Management Inc. grew its stake in shares of Kenvue by 71.2% during the 1st quarter.
MV Capital Management Inc. now owns 1,544 shares of the company’s stock valued at $33,000 after buying an additional 642 shares during the period. Finally, Cove Private Wealth LLC grew its stake in shares of Kenvue by 1.
6% during the 2nd quarter. Cove Private Wealth LLC now owns 44,539 shares of the company’s stock valued at $810,000 after buying an additional 700 shares during the period. 97.
64% of the stock is currently owned by institutional investors and hedge funds. Analysts Set New Price Targets Several analysts have recently issued reports on KVUE shares. Piper Sandler boosted their price objective on shares of Kenvue from $20.
00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, September 23rd. UBS Group boosted their price objective on shares of Kenvue from $20.
00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Kenvue from $23.
00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Citigroup lowered their price objective on shares of Kenvue from $21.
00 to $20.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. Finally, Royal Bank of Canada cut shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.
00 price target for the company. in a research report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock.
Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $22.10. Kenvue Stock Performance Shares of KVUE stock opened at $23.
26 on Monday. Kenvue Inc. has a 12 month low of $17.
67 and a 12 month high of $23.55. The company has a debt-to-equity ratio of 0.
69, a current ratio of 0.99 and a quick ratio of 0.68.
The firm has a market capitalization of $44.54 billion, a P/E ratio of 29.82, a P/E/G ratio of 2.
92 and a beta of 1.40. The company’s fifty day moving average price is $21.
41 and its two-hundred day moving average price is $20.07. Kenvue ( NYSE:KVUE – Get Free Report ) last issued its quarterly earnings data on Tuesday, August 6th.
The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.
04. Kenvue had a net margin of 7.23% and a return on equity of 21.
80%. The firm had revenue of $4 billion for the quarter, compared to analyst estimates of $3.93 billion.
During the same quarter in the previous year, the business posted $0.32 EPS. The firm’s revenue was down .
3% compared to the same quarter last year. On average, research analysts anticipate that Kenvue Inc. will post 1.
08 earnings per share for the current fiscal year. Kenvue Increases Dividend The business also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were paid a $0.
205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.
53%. The ex-dividend date was Wednesday, August 14th. This is a positive change from Kenvue’s previous quarterly dividend of $0.
20. Kenvue’s dividend payout ratio is 105.13%.
Kenvue Profile ( Free Report ) Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Articles Five stocks we like better than Kenvue How to Choose Top Rated Stocks 3 Bargain Stocks Under $20 With Major Growth Potential Natural Gas Prices Continue To Rally, These Stocks Should Benefit Top 5 ETFs to Own Now and Into 2025 The Risks of Owning Bonds Watch These 3 Former Short-Squeeze Stocks for a Big Rally Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. ( NYSE:KVUE – Free Report ).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter ..
